Abstract:The vast majority of cerebral stroke cases are caused by transient or permanent occlusion of a cerebral blood vessel (“ischemic stroke”) eventually leading to brain infarction. The final infarct size and the neurological outcome depend on a multitude of factors such as the duration and severity of ischemia, the existence of collateral systems and an adequate systemic blood pressure, etiology and localization of the infarct, but also on age, sex, comorbidities with the respective multimedication and genetic background. Thus, ischemic stroke is a highly complex and heterogeneous disorder. It is immediately obvious that experimental models of stroke can cover only individual specific aspects of this multifaceted disease. A basic understanding of the principal molecular pathways induced by ischemia-like conditions comes already from in vitro studies. One of the most frequently used in vivo models in stroke research is the endovascular suture or filament model in rodents with occlusion of the middle cerebral artery (MCA), which causes reproducible infarcts in the MCA territory. It does not require craniectomy and allows reperfusion by withdrawal of the occluding filament. Although promptly restored blood flow is far from the pathophysiology of spontaneous human stroke, it more closely mimics the therapeutic situation of mechanical thrombectomy which is expected to be increasingly applied to stroke patients. Direct transient or permanent occlusion of cerebral arteries represents an alternative approach but requires craniectomy. Application of endothelin-1, a potent vasoconstrictor, allows induction of transient focal ischemia in nearly any brain region and is frequently used to model lacunar stroke. Circumscribed and highly reproducible cortical lesions are characteristic of photothrombotic stroke where infarcts are induced by photoactivation of a systemically given dye through the intact skull. The major shortcoming of this model is near complete lack of a penumbra. The two models mimicking human stroke most closely are various embolic stroke models and spontaneous stroke models. Closeness to reality has its price and goes along with higher variability of infarct size and location as well as unpredictable stroke onset in spontaneous models versus unpredictable reperfusion in embolic clot models.

Etiology of Stroke and Choice of Models

A Rat Model of Studying Tissue-Type Plasminogen Activator Thrombolysis in Ischemic Stroke with Diabetes

Acute ischemic stroke: Overview of major experimental rodent models, pathophysiology, and therapy of focal cerebral ischemia

Comparison of Large Animal Models for Acute Ischemic Stroke: Which Model to Use?

Rodent Models of Ischemic Stroke: A Useful Tool for Stroke Drug Development

Animal Models for Ischemic Stroke

Ischemic stroke: experimental models and reality

A Clinically Relevant Model of Focal Embolic Cerebral Ischemia by Thrombus and Thrombolysis in Rhesus Monkeys.

Animal models of cerebral ischemia: A review

Rodent Models for Intravascular Ischemic Cerebral Infarction: a Review of Influencing Factors and Method Optimization

Endovascular ischemic stroke models of adult rhesus monkeys: a comparison of two endovascular methods

Stroke-prone Renovascular Hypertensive Rat As an Animal Model for Stroke Studies: from Artery to Brain

Cerebral Ischemia Models in Rats

Animal Models in Studying Cerebral Arteriovenous Malformation

Rodent Models of Vascular Cognitive Impairment

Preclinical models of middle cerebral artery occlusion: new imaging approaches to a classic technique

A Novel Improved Thromboembolism-Based Rat Stroke Model That Meets the Latest Standards in Preclinical Studies

Mouse stroke models and strains-related differences in susceptibility to cerebral ischemia]

Small Mammalian Animal Models of Heart Disease.

Increased Sensitivity in Detection of Deficits Following Two Commonly Used Animal Models of Stroke

Animal Models for Cardiovascular Research